Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CNS patents

This article was originally published in The Tan Sheet

Executive Summary

The U.S. Patent & Trademark Office will reexamine two of CNS' nasal strip patents, the Minneapolis-based Breathe Right manufacturer says Nov. 24. The review comes at the behest of Silver Eagle Labs, a defendant in a patent infringement case filed by CNS earlier this year; Silver Eagle counterclaimed that the patents are invalid. CNS CEO Marti Morfitt says the firm is "confident of the strength of our patents and we will continue to aggressively defend them." CNS is planning to ship two Breathe Right line extensions in early 2005 ("1The Tan Sheet" Nov. 22, 2004, In Brief)...

The U.S. Patent & Trademark Office will reexamine two of CNS' nasal strip patents, the Minneapolis-based Breathe Right manufacturer says Nov. 24. The review comes at the behest of Silver Eagle Labs, a defendant in a patent infringement case filed by CNS earlier this year; Silver Eagle counterclaimed that the patents are invalid. CNS CEO Marti Morfitt says the firm is "confident of the strength of our patents and we will continue to aggressively defend them." CNS is planning to ship two Breathe Right line extensions in early 2005 ("1 The Tan Sheet' Nov. 22, 2004, In Brief)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel